本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BioCryst製藥

8.12
-0.1700-2.05%
盤後8.120.00000.00%19:53 EDT
成交量:359.18萬
成交額:2,931.45萬
市值:20.75億
市盈率:-5.39
高:8.40
開:8.30
低:8.11
收:8.29
52周最高:11.22
52周最低:6.00
股本:2.56億
流通股本:2.22億
量比:0.66
換手率:1.62%
股息:- -
股息率:- -
每股收益(TTM):-1.5054
每股收益(LYR):1.21
淨資產收益率:587.33%
總資產收益率:52.86%
市淨率:-4.57
市盈率(LYR):6.71

資料載入中...

2020/02/25

重要事件披露

Current report, items 5.02 and 9.01
2020/02/18

重要事件披露

Current report, items 8.01 and 9.01
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/03

重要事件披露

Current report, items 8.01 and 9.01
2020/01/22

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/15

重要事件披露

Current report, items 8.01 and 9.01
2020/01/13

重要事件披露

Current report, items 5.02, 7.01, and 9.01
2019/12/11

重要事件披露

Current report, items 8.01 and 9.01
2019/11/21

重要事件披露

Current report, items 1.01 and 9.01
2019/11/20

重要事件披露

Current report, items 1.01 and 9.01
2019/11/19

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/18

重要事件披露

Current report, items 8.01 and 9.01
2019/11/08

季度報告

Quarterly report [Sections 13 or 15(d)]